Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate

Br J Dermatol. 2011 Jun;164(6):1406-7. doi: 10.1111/j.1365-2133.2011.10316.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Bradykinin / analogs & derivatives*
  • Bradykinin / therapeutic use
  • Bradykinin Receptor Antagonists*
  • Complement C1 Inhibitor Protein / therapeutic use*
  • Drug Resistance
  • Drug Tolerance
  • Female
  • Hereditary Angioedema Types I and II / drug therapy*
  • Humans

Substances

  • Bradykinin Receptor Antagonists
  • Complement C1 Inhibitor Protein
  • icatibant
  • Bradykinin